Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management

Affiliations

• ¹ The Benchmarking Partnership, Alsager, UK.
• ² Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK.
• ³ The School of Medicine and Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.
• ⁴ Res Consortium, Andover, UK.
• ⁵ St. Helens & Knowsley Teaching Hospitals NHS Trust, Whiston Hospital, Prescot, UK.
• ⁶ Department of Clinical Biochemistry, The Royal Oldham Hospital, The Northern Care Alliance NHS Group, Oldham, UK.
• ⁷ School of Medicine, Keele University, Keele, Staffordshire, UK.
• ⁸ Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK.
• ⁹ Department of Diabetes and Endocrinology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK.
• ¹⁰ Centre for Health & Development, Staffordshire University, Stoke-on-Trent, Staffordshire, UK.
• ¹¹ Department of Obstetrics & Gynaecology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK.
• ¹² Department of Clinical Biochemistry, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.
• ¹³ Department of Pathology, Warrington & Halton Teaching Hospitals NHS Foundation Trust, Warrington, UK.